Utility of gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage in premenopausal women with breast cancer: a systematic review and meta-analysis

BACKGROUND: Premature ovarian failure and infertility following chemotherapy are major concerns for premenopausal women with breast cancer. A potential ovarian function preservation strategy is administration of gonadotropin-releasing hormone (GnRH) agonists during adjuvant chemotherapy; however, st...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Yan-Wei, Zhang, Xiao-Man, Lv, Meng, Chen, Ling, Qin, Tian-Jie, Wang, Fan, Yang, Jiao, Liu, Pei-Jun, Yang, Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4654551/
https://www.ncbi.nlm.nih.gov/pubmed/26622183
http://dx.doi.org/10.2147/OTT.S95936

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4654551/
https://www.ncbi.nlm.nih.gov/pubmed/26622183
http://dx.doi.org/10.2147/OTT.S95936

Ejemplares similares